These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30660493)

  • 61. Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy.
    Kachanov M; Budäus L; Witt JH; Wagner C; Zinke J; Fangmeyer B; Schütte A; Spieker T; Beyersdorff D; Graefen M; Rachubinski P; Leyh-Bannurah SR
    World J Urol; 2022 Dec; 40(12):2955-2961. PubMed ID: 36357604
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Which protocol for prostate biopsies in patients with a positive MRI? Interest of systematic biopsies by sectors.
    Zambon A; Nguyen TA; Fourcade A; Segalen T; Saout K; Deruelle C; Joulin V; Tissot V; Doucet L; Fournier G; Valeri A
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):500-506. PubMed ID: 38114598
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
    Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
    BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies.
    Jager A; van Riel LAMJG; Postema AW; de Reijke TM; van der Sluis TM; Oddens JR
    Ther Adv Urol; 2022; 14():17562872221111410. PubMed ID: 35924207
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fusion-targeted biopsy significantly improves prostate cancer detection in biopsy-naïve men.
    Blas L; Shiota M; Tsukahara S; Goto S; Kinoshita F; Matsumoto T; Monji K; Kashiwagi E; Inokuchi J; Eto M
    Int J Urol; 2023 Jul; 30(7):600-604. PubMed ID: 37078488
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Image-guided multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsy augmented with a sextant versus an extended template random biopsy: Comparison of cancer detection rates, complication and functional outcomes.
    Adams ES; Deivasigamani S; Kotamarti S; Wolf S; Mottaghi M; Aminsharifi A; Taha T; Seguier D; Michael Z; Ivey M; Gupta RT; Polascik TJ
    Prostate; 2024 Sep; 84(13):1224-1233. PubMed ID: 38926139
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men.
    Russo F; Mazzetti S; Regge D; Ambrosini I; Giannini V; Manfredi M; De Luca S; Bollito E; Porpiglia F
    Eur Urol Oncol; 2021 Dec; 4(6):855-862. PubMed ID: 33893066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
    Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
    Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
    [TBL] [Abstract][Full Text] [Related]  

  • 69. There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies.
    Dell'Oglio P; Stabile A; Soligo M; Brembilla G; Esposito A; Gandaglia G; Fossati N; Bravi CA; Dehò F; De Cobelli F; Montorsi F; Karnes RJ; Briganti A
    Eur Urol Oncol; 2020 Feb; 3(1):112-118. PubMed ID: 31411973
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.
    Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M
    BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiparametric MRI/ultrasound fusion-guided biopsy decreases detection of indolent cancer in African-American men.
    Kongnyuy M; Siddiqui MM; George AK; Muthigi A; Sidana A; Maruf M; Turkbey B; Choyke PL; Wood BJ; Pinto PA
    Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):348-351. PubMed ID: 28440325
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men.
    Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Fascelli M; Kadakia M; Frye TP; Ho R; Mertan F; Minhaj Siddiqui M; Su D; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
    Urol Oncol; 2016 Jun; 34(6):254.e15-21. PubMed ID: 26905304
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Limitations of overlapping cores in systematic and MRI-US fusion biopsy.
    Lee AY; Yang XY; Lee HJ; Law YM; Huang HH; Sim AS; Lau WK; Lee LS; Cheng CW; Ho HS; Yuen JS; Tay KJ; Chen K
    Urol Oncol; 2021 Nov; 39(11):782.e15-782.e21. PubMed ID: 33888423
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tailoring biopsy strategy in the MRI-fusion prostate biopsy era: systematic, targeted or neither?
    Jäderling F; Bergman M; Engel JC; Mortezavi A; Picker W; Haug ES; Eklund M; Nordström T
    BMC Urol; 2024 Aug; 24(1):168. PubMed ID: 39112967
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
    Mazzone E; Stabile A; Pellegrino F; Basile G; Cignoli D; Cirulli GO; Sorce G; Barletta F; Scuderi S; Bravi CA; Cucchiara V; Fossati N; Gandaglia G; Montorsi F; Briganti A
    Eur Urol Oncol; 2021 Oct; 4(5):697-713. PubMed ID: 33358543
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Magnetic Resonance Imaging-targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer.
    Alkema NG; Hoogeveen SFJS; Cauberg ECC; Witte LPW; van 't Veer-Ten Kate M; de Boer E; Hoogland MAM; Blanker MH; Boomsma MF; Steffens MG
    Eur Urol Open Sci; 2022 Oct; 44():125-130. PubMed ID: 36185584
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
    Acta Radiol; 2018 Mar; 59(3):371-380. PubMed ID: 28679325
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysis.
    Avolio PP; Lughezzani G; Paciotti M; Maffei D; Uleri A; Frego N; Hurle R; Lazzeri M; Saita A; Guazzoni G; Casale P; Buffi NM
    Urol Oncol; 2021 Dec; 39(12):832.e1-832.e7. PubMed ID: 34183255
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predictive clinical features for negative histopathology of MRI/Ultrasound-fusion-guided prostate biopsy in patients with high likelihood of cancer at prostate MRI: Analysis from a urologic outpatient clinic1.
    Apfelbeck M; Pfitzinger P; Bischoff R; Rath L; Buchner A; Mumm JN; Schlenker B; Stief CG; Chaloupka M; Clevert DA
    Clin Hemorheol Microcirc; 2020; 76(4):503-511. PubMed ID: 33337358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.